BHATIA SANGEETA N. sold 6.1% of their position (318.00 shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $134.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/5/2026ACC: 0000875320-26-000175
Director
Since Oct 2018
+625.00
Net shares
Net buyer
$134.7K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
943.00 acquired · 318.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+943.00
Price / share
—
Trade value
—
% of position
21.9%
5/1/2026
4.30K→5.24K
Common Stock
Direct
Shares
−318.00
Price / share
$423.73
Trade value
$134.75K
% of position
6.1%
5/4/2026
5.24K→4.92K
Total
Net shares
+625.00
Net value
-$134.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | A · Award | +943.00 | — | — | 21.9% | 4.30K | 5.24K |
| Common Stock Direct | 5/4/2026 | S · Sale | −318.00 | $423.73 | $134.75K | 6.1% | 5.24K | 4.92K |
| Total | +625.00 | -$134.75K | ||||||
Derivative Transactions0
No derivative transactions reported